Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Differentieret implementering af HPVbaseret screening i dansk livmoderhalskræftscreening

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Forbedring af overlevelsen efter hjertestop uden for hospital

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Rekombinant faktor VIIa ved post partum-blødning

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Azathioprinhypersensitivitetssyndrom

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Behandling af medicinske komorbiditeter ved demens

    Research output: Contribution to journalReviewResearchpeer-review

  5. Genterapi mod arvelige øjensygdomme

    Research output: Contribution to journalReviewResearchpeer-review

  1. Labor augmentation with oxytocin in low- and lower-middle-income countries: a systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. Multivitamin use and risk of preeclampsia: A systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  3. Reply: Multivitamin use may lower risk of preeclampsia: A meta-analysis

    Research output: Contribution to journalLetterResearchpeer-review

  4. Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.

Translated title of the contributionPhased implementation of HPV-based cervical cancer screening in Denmark
Original languageDanish
Article numberV04210327
JournalUgeskrift for Laeger
Volume184
Issue number16
ISSN0041-5782
Publication statusPublished - 22 Aug 2022

Bibliographical note

Publisher Copyright:
© 2022. Ugeskrift for Laeger.All Rights Reserved

ID: 84665264